EyePoint Pharmaceuticals Inc (EYPT)
16.16
-0.31
(-1.88%)
USD |
NASDAQ |
Apr 25, 16:00
16.16
0.00 (0.00%)
After-Hours: 20:00
EyePoint Pharmaceuticals Price to Book Value: 3.024 for April 25, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 25, 2024 | 3.024 |
| April 24, 2024 | 3.082 |
| April 23, 2024 | 3.288 |
| April 22, 2024 | 3.172 |
| April 19, 2024 | 3.302 |
| April 18, 2024 | 3.274 |
| April 17, 2024 | 3.918 |
| April 16, 2024 | 4.086 |
| April 15, 2024 | 3.982 |
| April 12, 2024 | 4.200 |
| April 11, 2024 | 4.283 |
| April 10, 2024 | 4.062 |
| April 09, 2024 | 4.028 |
| April 08, 2024 | 3.879 |
| April 05, 2024 | 3.794 |
| April 04, 2024 | 3.770 |
| April 03, 2024 | 3.882 |
| April 02, 2024 | 3.794 |
| April 01, 2024 | 3.793 |
| March 28, 2024 | 3.868 |
| March 27, 2024 | 3.894 |
| March 26, 2024 | 3.86 |
| March 25, 2024 | 4.058 |
| March 22, 2024 | 4.165 |
| March 21, 2024 | 4.382 |
| Date | Value |
|---|---|
| March 20, 2024 | 4.369 |
| March 19, 2024 | 4.135 |
| March 18, 2024 | 3.985 |
| March 15, 2024 | 4.019 |
| March 14, 2024 | 4.068 |
| March 13, 2024 | 4.133 |
| March 12, 2024 | 4.268 |
| March 11, 2024 | 4.279 |
| March 08, 2024 | 4.565 |
| March 07, 2024 | 4.736 |
| March 06, 2024 | 4.816 |
| March 05, 2024 | 4.784 |
| March 04, 2024 | 4.848 |
| March 01, 2024 | 5.239 |
| February 29, 2024 | 5.011 |
| February 28, 2024 | 5.097 |
| February 27, 2024 | 5.280 |
| February 26, 2024 | 4.889 |
| February 23, 2024 | 4.888 |
| February 22, 2024 | 4.806 |
| February 21, 2024 | 4.904 |
| February 20, 2024 | 5.102 |
| February 16, 2024 | 5.213 |
| February 15, 2024 | 5.355 |
| February 14, 2024 | 5.326 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.5924
Minimum
Dec 19 2022
26.93
Maximum
Jan 28 2020
6.732
Average
4.806
Median
Dec 20 2021
Price to Book Value Benchmarks
| INVO Bioscience Inc | -- |
| Bio-Path Holdings Inc | 4.056 |
| Ocular Therapeutix Inc | 6.850 |
| Aileron Therapeutics Inc | 12.32 |
| Apellis Pharmaceuticals Inc | 29.71 |
Price to Book Value Related Metrics
| PS Ratio | 13.66 |
| Price | 16.16 |
| Earnings Yield | -11.26% |
| Market Cap | 805.27M |